An open, non-controlled clinical study to assess the efficacy and safety of the recombinant human alpha 2b pegylated interferon PEG-Heberon® plus ribavirin for the treatment of chronic hepatitis C virus infection in Cuban patients
|
|
| Biotecnología Aplicada. 2015 oct.-dic.; 32(4) |
4201
|
|
Texto Completo(PDF-287 KB)
Cómo citar |
|
|
|
Evaluation of morphological damage caused by a low molecular weight chitosan on the fungus Bipolaris oryzae
|
|
| Biotecnología Aplicada. 2015 oct.-dic.; 32(4) |
4211
|
|
Texto Completo(PDF-259 KB)
Cómo citar |
|
|
|
Protein enrichement of fruit processing byproducts using
solid state fermentation with Saccharomyces cerevisiae
and Bacillus subtilis
|
|
| Biotecnología Aplicada. 2015 oct.-dic.; 32(4) |
4221
|
|
Texto Completo(PDF-313 KB)
Cómo citar |
|
|
|
Effects of two formulations containing the IFN alpha 2b and IFN gamma on the main clinical, hematological and biochemical parameters in non-human primates from Chlorocebus aethiops sabaeus species
|
|
| Biotecnología Aplicada. 2015 oct.-dic.; 32(4) |
4231
|
|
Texto Completo(PDF-300 KB)
Cómo citar |
|
|
|
Cytotoxic effect of an alumina matrix composite with APTS-functionalized carbon nanotubes in Vero cells
|
|
| Biotecnología Aplicada. 2015 oct.-dic.; 32(4) |
4241
|
|
Texto Completo(PDF-384 KB)
Cómo citar |
|
|
|
Pre-formulation study of a pentavalent DTP-HB-Hib vaccine obtained in Ecuador
|
|
| Biotecnología Aplicada. 2015 oct.-dic.; 32(4) |
4251
|
|
Texto Completo(PDF-461 KB)
Cómo citar |
|
|
|
